NRx Pharmaceuticals Inc.
4.43
-0.67 (-13.14%)
At close: Jan 15, 2025, 12:29 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 4.59M 20.05M 27.61M 1.86M 6.00 11.08K 449.37K
Short-Term Investments n/a n/a n/a 5.97M 32.01M 70.77M 69.03M
Long-Term Investments n/a n/a n/a n/a 32.01M 70.77M 69.03M
Other Long-Term Assets 431.00K 21.00K 15.00K 11.00K 1.00 n/a n/a
Receivables 6.00K n/a n/a 831.00K n/a n/a n/a
Inventory n/a -7.00K n/a 214.00K n/a n/a n/a
Other Current Assets 2.28M 11.48M 5.11M 240.00K 69.48K 19.11K 87.00K
Total Current Assets 6.88M 25.80M 32.71M 2.93M 69.49K 30.19K 536.38K
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 431.00K 21.00K 15.00K 11.00K 32.01M 70.77M 69.03M
Total Assets 7.32M 25.82M 32.73M 2.94M 32.07M 70.80M 69.57M
Account Payables 4.63M 2.08M 3.69M 3.15M 622.44K 551.10K 85.67K
Deferred Revenue n/a n/a 2.84M n/a n/a n/a n/a
Short-Term Debt 9.16M 7.70M 518.00K 249.00K n/a n/a n/a
Other Current Liabilities 5.25M 5.81M 7.72M 42.71M -69.48K n/a 7.50K
Total Current Liabilities 19.05M 16.59M 11.92M 46.16M 622.44K 567.41K 93.17K
Long-Term Debt n/a 2.82M n/a 548.00K 1.95M 690.00K n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 1.82M n/a 548.00K 1.95M 690.00K n/a
Total Liabilities 19.05M 18.41M 11.92M 46.71M 2.57M 1.26M 93.17K
Total Debt 9.16M 10.53M 518.00K 797.00K 1.95M 690.00K n/a
Common Stock 84.00K 67.00K 59.00K 43.00K 24.50M 64.54M 64.48M
Retained Earnings -253.15M -223.06M -183.24M -90.18M 369.50K -38.93K -105.03K
Comprehensive Income -3.00K n/a n/a n/a -24.50M n/a n/a
Shareholders Equity -11.73M 7.41M 20.81M -43.77M 29.50M 69.54M 69.47M
Total Investments n/a n/a n/a 5.97M 32.01M 70.77M 69.03M

Create Price Alert on NRXP

Your price alert will notify you when the stock price is above 4.43.

Add to Watchlist